Carregant...
Comparative effectiveness of prostate cancer screening between ages 55 and 69 followed by Active Surveillance.
BACKGROUND: Following the recent USPSTF’s Grade “C” draft recommendation for prostate cancer screening between ages 55 and 69, there is a need to determine whether this could be cost-effective in a US population setting. METHODS: We use a microsimulation model of screening and active surveillance (A...
Guardat en:
| Publicat a: | Cancer |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6680244/ https://ncbi.nlm.nih.gov/pubmed/29231973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.31141 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|